Connexins: synthesis, post-translational modifications, and trafficking in health and disease

T Aasen, S Johnstone, L Vidal-Brime, KS Lynn… - International journal of …, 2018 - mdpi.com
Connexins are tetraspan transmembrane proteins that form gap junctions and facilitate
direct intercellular communication, a critical feature for the development, function, and …

Molecular networks of FOXP family: dual biologic functions, interplay with other molecules and clinical implications in cancer progression

JH Kim, J Hwang, JH Jung, HJ Lee, DY Lee, SH Kim - Molecular cancer, 2019 - Springer
Abstract Though Forkhead box P (FOXP) transcription factors comprising of FOXP1, FOXP2,
FOXP3 and FOXP4 are involved in the embryonic development, immune disorders and …

RUNX1 maintains the identity of the fetal ovary through an interplay with FOXL2

B Nicol, SA Grimm, F Chalmel, E Lecluze… - Nature …, 2019 - nature.com
Sex determination of the gonads begins with fate specification of gonadal supporting cells
into either ovarian pre-granulosa cells or testicular Sertoli cells. This fate specification …

Estrogen, estrogen-like molecules and autoimmune diseases

J Merrheim, J Villegas, J Van Wassenhove… - Autoimmunity …, 2020 - Elsevier
In western countries, the slope of autoimmune disease (AD) incidence is increasing and
affects 5–8% of the population. Mainly prevalent in women, these pathologies are due to …

RUNX1‐dependent mechanisms in biological control and dysregulation in cancer

D Hong, AJ Fritz, JA Gordon, CE Tye… - Journal of cellular …, 2019 - Wiley Online Library
The RUNX1 transcription factor has recently been shown to be obligatory for normal
development. RUNX1 controls the expression of genes essential for proper development in …

RUNX1 is regulated by androgen receptor to promote cancer stem markers and chemotherapy resistance in triple negative breast cancer

NB Fernández, SM Sosa, JT Roberts, MS Recouvreux… - Cells, 2023 - mdpi.com
Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype for which no
effective targeted therapies are available. Growing evidence suggests that chemotherapy …

Suppression of breast cancer stem cells and tumor growth by the RUNX1 transcription factor

D Hong, AJ Fritz, KH Finstad, MP Fitzgerald… - Molecular Cancer …, 2018 - AACR
Breast cancer remains the most common malignant disease in women worldwide. Despite
advances in detection and therapies, studies are still needed to understand the mechanisms …

RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells

AJ Fritz, D Hong, J Boyd, J Kost… - Journal of cellular …, 2020 - Wiley Online Library
Breast cancer stem cells (BCSCs) are competent to initiate tumor formation and growth and
refractory to conventional therapies. Consequently BCSCs are implicated in tumor …

R‐spondin‐mediated WNT signaling potentiation in mammary and breast cancer development

JM Tocci, CM Felcher, ME García Solá, EC Kordon - IUBMB life, 2020 - Wiley Online Library
The mammary gland is a secretory organ, which develops as a network of growing epithelial
ducts composed of luminal and basal cells that invade the surrounding adipose tissue …

RUNX1 as a novel molecular target for breast cancer

NS Ariffin - Clinical Breast Cancer, 2022 - Elsevier
RUNX1 has long known for its role in hematopoiesis until recently it is implicated in human
breast cancer pathogenesis. This has drawn attention in research as elevated expression of …